Molecular Analysis for Precision Oncology Virtual Congress 2020: Abstracts

The abstract submission system is closed.

Outcome notifications

Outcome notifications are expected to be made available to first authors by the end of August 2020

Abstract submission deadlines

Trial in progress abstracts (TiP)

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to the MAP 2020.

It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis and consequently will only require the completion of two (2) sections:

• Background
• Trial design

Notes:

• Recruitment must have already begun or have been completed by the abstract submission deadline of 29 July 2020.
• Abstracts including results or preliminary data will be rejected.
• Trial in Progress abstracts will be accepted for Poster outcome only.

Abstracts will be reviewed by the MAP 2020 Scientific Committee and considered on the merits of the scientific and clinical rationale of the trial.

Publication schedule for accepted abstracts

Abstracts accepted for presentation at MAP 2020 as Proffered Paper and Poster will be published online on the ESMO website at 12:00 CEST on Monday, 5 October 2020.

Presentation options for accepted abstracts

Presenters may request an outcome based on the following options. The MAP 2020 Scientific Committee reserves the right to decide which of these session formats will be scheduled during the Congress.

Proffered Paper – Oral presentation by authors presenting original data of superior quality, followed by expert discussion and perspectives.

Poster – Display session for review, discussion and questions. Presenting authors must be available for Q&A for 45 minutes to represent their work.

All accepted abstracts will be published in the MAP 2020 Abstract Book, a supplement of the official ESMO journal Annals of Oncology.

More information can be found in the Abstract regulations